Latest Dyspepsia Stories
Patients with upper gastrointestinal (GI) complaints visit their general practitioner (GP) more often than patients with other conditions.
FD, a common non-organic disease in the world, greatly affects the patient's quality of life. However, treatment of FD is still controversial and no single therapy is uniformly effective, due, in part, to absence of a reliable evaluation instrument.
Findings of a Danish study suggest the use of proton pump inhibitors can produce acid-related symptoms in healthy adults. Proton pump inhibitors are a group of drugs used to cause a pronounced and long-lasting reduction of gastric acid production and are among the most widely selling drugs in the world, Wikipedia said. But results of an eight-week, randomized, double-blind placebo-controlled trial led by Dr.
Treatment with proton pump inhibitors (PPIs) for eight weeks induces acid-related symptoms like heartburn, acid regurgitation and dyspepsia once treatment is withdrawn in healthy individuals, according to a new study in Gastroenterology.
--Data from Phase 3 REDUCE-1 and REDUCE-2 Studies Demonstrate that Novel Combination Treatment Decreases Risk of Developing GI Ulcers by Approximately 50 Percent-- --Data presented today at 56th Annual Digestive Disease Week Meeting in Chicago-- CHICAGO, June 1 /PRNewswire/ -- Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today presented data at the 56th Annual Digestive Disease Week (DDW) meeting from two pivotal Phase 3 trials evaluating its lead compound...
Officials with the US Food and Drug Administration (FDA) are looking in to whether Plavix, a popular blood thinner used by millions, may be less effective in patients who also take certain heartburn medications.
The pain reliever acetaminophen is not free of gastrointestinal side effects at high doses, researchers in Turkey found. Dr. Alis Soylu and colleagues Dr. Sadi Konuk and Dr.
Some in South Korea experience chronic gastrointestinal symptoms fairly frequently, researchers said. Researchers led by Dr. Myung-Gyu Choi of the Kangnam St.
Chronic gastrointestinal symptoms are highly prevalent in different geographic populations and cause various gastrointestinal symptoms that greatly inconvenience the lives of those affected.
SKOKIE, Ill., Dec. 2 /PRNewswire/ -- Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT-501, met all primary endpoints.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.